- €15.11bn
- €31.49bn
- €4.29bn
- 63
- 46
- 78
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,665 | 2,770 | 3,297 | 3,515 | 4,288 |
Cost of Revenue | |||||
Gross Profit | 2,237 | 2,264 | 2,334 | 2,377 | 2,616 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,213 | 1,390 | 1,874 | 2,114 | 2,941 |
Operating Profit | 1,452 | 1,380 | 1,423 | 1,401 | 1,347 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,465 | 1,471 | 1,615 | 1,050 | 1,534 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,090 | 1,101 | 1,500 | 672 | 1,145 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,090 | 1,101 | 1,496 | 671 | 1,135 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,093 | 1,104 | 1,499 | 671 | 1,135 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.33 | 0.332 | 0.372 | 0.202 | 0.354 |
Dividends per Share |